This study found that brand price at launch and generic entry overstates long-run average pharmaceutical costs, with and without accounting for medical cost offsets.
Adrian Towse, MA, MPhil
Advertisement
Articles by Adrian Towse, MA, MPhil
Assessment of current trends, success factors, and challenges in the use of risk-sharing agreements in the US private sector.
Advertisement
Latest Updated Articles
- What Do Pharmaceuticals Really Cost in the Long Run?
August 22nd 2017
Advertisement
Advertisement
Trending on AJMC
1
Judge Denies Preliminary Injunction in Medicaid Work Requirements Case
2
AHRQ Grant Freeze Halts Patient Safety Research Nationwide
3
FDA Advisory Panel Votes Against Approval of Deramiocel for DMD
4
MASLD, MASH Linked to Higher Mild Cognitive Impairment Risk, Lower Dementia Odds
5